Cite
An Enhanced Dissolving Cyclosporin-A Inhalable Powder Efficiently Reduces SARS-CoV-2 Infection In Vitro
MLA
Davide D’Angelo, et al. “An Enhanced Dissolving Cyclosporin-A Inhalable Powder Efficiently Reduces SARS-CoV-2 Infection In Vitro.” Pharmaceutics, vol. 15, no. 3, Mar. 2023, p. 1023. EBSCOhost, https://doi.org/10.3390/pharmaceutics15031023.
APA
Davide D’Angelo, Eride Quarta, Stefania Glieca, Giada Varacca, Lisa Flammini, Simona Bertoni, Martina Brandolini, Vittorio Sambri, Laura Grumiro, Giulia Gatti, Giorgio Dirani, Francesca Taddei, Annalisa Bianchera, Fabio Sonvico, Ruggero Bettini, & Francesca Buttini. (2023). An Enhanced Dissolving Cyclosporin-A Inhalable Powder Efficiently Reduces SARS-CoV-2 Infection In Vitro. Pharmaceutics, 15(3), 1023. https://doi.org/10.3390/pharmaceutics15031023
Chicago
Davide D’Angelo, Eride Quarta, Stefania Glieca, Giada Varacca, Lisa Flammini, Simona Bertoni, Martina Brandolini, et al. 2023. “An Enhanced Dissolving Cyclosporin-A Inhalable Powder Efficiently Reduces SARS-CoV-2 Infection In Vitro.” Pharmaceutics 15 (3): 1023. doi:10.3390/pharmaceutics15031023.